Clinical Trial Update: A Study of Short-Term Outcomes and Economic Impact For Patients With Worsening Congestive Heart Failure When Natrecor (Nesiritide) is Added to Standard-Care Therapy, Compared to Administration of Placebo With Standard-Care Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adding nesiritide (Natrecor) to standard-care therapy versus placebo in patients with worsening congestive heart failure, assessing sho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Heart Failure
• Paroxysmal Nocturnal Dyspnea

Drugs mentioned

• Natrecor (nesiritide)

Snippet

Sponsor: Scios, Inc. | Conditions: Cardiomyopathies, Heart Failure, Congestive | Phase 3 | Status: COMPLETED